Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

CUSIP: 055477103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
63,302,078
Total 13F shares
57,096,017
Share change
+6,913,932
Total reported value
$960,809,333
Price per share
$16.83
Number of holders
140
Value change
+$119,906,754
Number of buys
88
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q4 2025

As of 31 Dec 2025, Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,096,017 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, FMR LLC, T. Rowe Price Investment Management, Inc., RED TREE MANAGEMENT, LLC, TPG GP A, LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, and BlackRock, Inc.. This page lists 140 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.